ARP39721_T100

antibody from Aviva Systems Biology

Targeting: RIOX2 FLJ14393, JMJD10, mdig, MINA, MINA53, NO52

Western blot (Supportive data in Antibodypedia)

Immunohistochemistry (Supportive data in Antibodypedia)

Antibody Data

Product number

ARP39721_T100

Provider

Aviva Systems Biology

Proper citation

Aviva Systems Biology Cat#ARP39721_T100, RRID:AB_841551

Product name

MINA antibody - N-terminal region (ARP39721_T100)

Antibody type

Polyclonal

Antigen

The immunogen is a synthetic peptide directed towards the N terminal region of human MINA

Description

Protein A purified

Reactivity

Human, Rat, Horse, Porcine, Rabbit

Host

Rabbit

Vial size

100 μl

Concentration

Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.

Storage

For short term use, store at 2-8C up to 1 week. For long term storage, store at -20C in small aliquots to prevent freeze-thaw cycles.

Western blot

Supportive validation

Submitted by

Aviva Systems Biology (provider)

Main image

Experimental details

WB Suggested Anti-MINA Antibody Titration: 0.25ug/ml, ELISA Titer: 1:62500, Positive Control: Human Thymus

Sample type

Human Thymus

Primary Ab dilution

4-8 µg/mL

Protocol

Protocol

Immunohistochemistry

Supportive validation

Submitted by

Aviva Systems Biology (provider)

Main image

Experimental details

Immunohistochemistry staining of Human Intestine with Anti-MINA antibody

Sample type

Human Intestine

Validation comment

This location is supported by literature

Primary Ab dilution

4.0-8.5252

Secondary Ab

Secondary Ab

Secondary Ab dilution

0.5ug/mL – 0.2ug/mL

Protocol

Protocol

Supportive validation

Submitted by

Aviva Systems Biology (provider)

Main image

Experimental details

Immunohistochemistry with Human Intestine tissue at an antibody concentration of 4-8µg/ml using anti-MINA antibody (ARP39721_T100)

Sample type

Human Intestine

Primary Ab dilution

0.25 µg/mL

Protocol

Protocol